Colorectal cancer develops in the colon or rectum, often from polyps or as metastases from other cancers. Risk factors include inflammatory bowel disease, genetic predispositions
Pancreatic cancer originates in the pancreas, often as ductal adenocarcinoma or as metastases from other cancers. Risk factors include smoking, diabetes, chronic pancreatitis, and genetic predispositions.
Stomach cancer, also known as gastric cancer, is a formidable health challenge globally, with its aggressive progression and complex treatment requirements.
Lung cancer, a leading cause of cancer-related deaths worldwide, presents significant challenges due to its aggressive nature and complex treatment needs.
Liver cancer, a life-threatening condition, poses significant challenges worldwide, requiring targeted and innovative treatments for effective outcomes.
Colon cancer originates in the large intestine, often progressing from benign polyps to malignant tumors. It ranges from early stage, localized cancers to advanced, metastatic disease.
Testicular cancer, a rare but treatable malignancy, impacts young men most often, demanding innovative and effective solutions for lasting recovery.
Dendritic cell immunotherapy mobilizes dendritic cells, the immune system’s sentinels, to present leukemia-specific antigens to T-cells, sparking a precise attack on cancer cells.
Germany primarily utilizes adult stem cells offering therapies for conditions ranging from neurological and orthopedic disorders to autoimmune diseases and chronic wounds.
Germany emerges as a beacon of hope, leading the charge with dendritic cell therapy, a personalized immunotherapy that harnesses the body’s immune system to target cancer cells with precision.
On the other hand, melanoma arises from melanocytes, the pigment-producing cells in the skin, and is significantly more dangerous due to its tendency to spread rapidly to other parts of the body.
Bladder cancer originates in the urothelial cells lining the bladder, with ~75% of cases being non-muscle invasive bladder cancer (NMIBC), confined to the mucosa or submucosa.
Dendritic cell therapy is an advanced immunotherapy that harnesses dendritic cells, the immune system’s key antigen-presenting cells to trigger a targeted immune response against kidney cancer (renal cell carcinoma, RCC)
Prof. Dr. Frank Gansauge, with over 20 years of expertise in oncology and immunotherapy, is a pivotal figure in delivering personalized dendritic cell vaccine therapies in Germany.
Dendritic cell therapy is an advanced immunotherapy that utilizes dendritic cells, the immune system’s antigen-presenting cells, to stimulate a targeted immune response against colon cancer.
Our benefits:
.webp)
 (1).webp)
.webp)
.jpg)
 (1).webp)
.jpg)
